Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Dis...

FDA Recall #D-0171-2025 — Class II — December 10, 2024

Recall #D-0171-2025 Date: December 10, 2024 Classification: Class II Status: Ongoing

Product Description

Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona Pharmaceuticals Inc., Cranford, NJ 07016, NDC 72578-094-02. packaged in an Airless pump pack

Reason for Recall

Crystallization

Recalling Firm

VIONA PHARMACEUTICALS INC — Cranford, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

23304 packs

Distribution

US Nationwide

Code Information

Lots T400513, Exp Date 02/2026; T400807, Exp Date 03/2026; T401152, Exp Date 06/2026; T401303, Exp Date 07/2026; T401304, Exp Date 07/2026; T401399, Exp Date 07/2026 & T401696 Exp Date 08/2026.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated